Skip to search formSkip to main contentSkip to account menu

somatostatin receptor ligand

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
OR23-07 Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study of Oral Octreotide Capsules in Adult Patients with Acromegaly
Abstract Many patients taking long-acting somatostatin receptor ligand (SRL) injections as first-line medical therapy in… 
2020
2020
MON-297 Withdrawal from Long-Acting Somatostatin Receptor Ligand Injections in Adult Patients with Acromegaly: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL…
Abstract Data on the impact of withdrawal from long-acting somatostatin receptor ligand (SRL) injections on disease activity in… 
2020
2020
SAT-267 Pregnancy in Acromegaly: Report of Five Cases
Abstract Introduction: In acromegaly, there are changes in growth hormone (GH), insulin-like growth factor-1 (IGF-1) and insulin… 
Review
2015
Review
2015
Medical treatment of acromegaly in pregnancy, highlights on new reports
In this issue of Endocrine, van der Lely et al. [1] provided a well-written, extensive review of all reported cases of… 
2014
2014
Abstract CT306: Breast cancer chemoprevention by IGF-I inhibition in women with atypical hyperplasia of the breast: A phase 1/2 proof of principle trial
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA SERMs are effective in breast cancer prevention in women… 
2007
2007
Thyrotropinoma response to somatostatin receptor ligand (SRL) key feature in preoperative treatment
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)